UK Watchdog Accuses Merck Of Arthritis Drug Scheme
The U.K.'s Competition and Markets Authority provisionally found Tuesday that pharmaceutical company Merck Sharp & Dohme Ltd. has operated an anti-competitive discount scheme for its popular brand-name arthritis medicine Remicade in...To view the full article, register now.
Already a subscriber? Click here to view full article